Viewing Study NCT00642902


Ignite Creation Date: 2025-12-25 @ 3:55 AM
Ignite Modification Date: 2026-01-29 @ 7:22 AM
Study NCT ID: NCT00642902
Status: TERMINATED
Last Update Posted: 2016-05-24
First Post: 2008-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)
Sponsor: EMD Serono
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing Multiple Sclerosis View
None Atacicept View